Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Arthritis and Rheumatism|January 22, 2000
Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphomaS De Vita, V De Re, D Gasparotto, et al.
Gastroenterology|June 1, 1996
Widespread clonal B-cell disorder in Sjögren's syndrome predisposing to Helicobacter pylori-related gastric lymphomaS De Vita, G Ferraccioli, C Avellini, et al.
Scandinavian Journal of Gastroenterology|October 1, 1994
Mild sialoadenitis: a common finding in patients with hepatitis C virus infectionM Pirisi, C Scott, C Fabris, et al.
Rheumatology (Oxford, England)|January 19, 2006
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroidsL Quartuccio, G Soardo, G Romano, et al.
Rheumatology (Oxford, England)|June 1, 2006
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infectionM Fabris, L Quartuccio, S Sacco, et al.
Reumatismo|December 17, 2009
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]S Bombardieri, G Ferraccioli, C Ferri, et al.
Scandinavian Journal of Rheumatology|March 16, 2018
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategyA L Fedele, L Petricca, B Tolusso, et al.
Arthritis and Rheumatism|August 1, 1982
Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritisG Pasero, P Pellegrini, U Ambanelli, et al.
The Journal of Rheumatology|September 1, 1995
Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndromeS De Vita, R Dolcetti, G Ferraccioli, et al.
Blood|September 1, 1995
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemiaS De Vita, D Sansonno, R Dolcetti, et al.
Pageof 8